Key facts
- This page summarizes Jeffrey G. Black's Form 4 filing for STANDARD BIOTOOLS INC. (LAB).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 19 Aug 2024, 17:30.
Jeffrey G. Black - 15 Aug 2024 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)
- Reporting relationship
- SVP & Chief Financial Officer
- Issuer ticker
- LAB
- Reported as of
- 15 Aug 2024
- Net transaction value
- -$7,277
- SEC form
- 4
- Accepted by SEC
- 19 Aug 2024, 17:30:02 UTC
- Prior SEC filing
- 21 May 2024
- Next SEC filing
- 05 Sep 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/Jeffrey G Black by Agnieszka Gallagher, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jeffrey G. Black filed Form 4 for STANDARD BIOTOOLS INC. (LAB) on 19 Aug 2024.
Change
- Previous filing in this sequence was filed on 21 May 2024.
- Current net transaction value: -$7,277.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LAB
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +13,157
- Change %
- +3.1%
- Price
- $0.000000
- Shares after
- 432,993
- Date
- 15 Aug 2024
- Ownership
- Direct
LAB
transaction
Common Stock
Tax liability
- Transaction value
- $7,277
- Shares
- -4,695
- Change %
- -1.1%
- Price
- $1.55
- Shares after
- 428,298
- Date
- 15 Aug 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
LAB
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -13,157
- Change %
- -8.3%
- Price
- $0.000000
- Shares after
- 144,738
- Date
- 15 Aug 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 13,157
- Exercise price
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units ("RSUs") granted to the reporting person on May 15, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 17, 2023.
Footnote F2
Each RSU represents the contingent right to receive one share of the Issuer's common stock.
Footnote F3
On May 15, 2023, the Reporting Person was granted 210,526 RSUs. 1/4th of the RSUs vested on May 15, 2024 and 1/16th of the RSUs vested on August 15, 2024. The remaining unvested RSUs will be forfeited due to the resignation of the Reporting Person effective as of August 31, 2024.